Braak stage 1, 100% of pigmented neurons left
parkinsonconnecting

Receipt 8221

A sealed prediction that did not hold.

no effect in discovery (spearman rho -0.07, p 0.851). This receipt's hash covers every field on it, plus the hash of receipt 8220, so changing any earlier receipt would break every one after it. Your browser recomputes it below.

The slip

  1. PARKINSON RECEIPTno. 8221
    24 Oct 2026, 03:09 UTC

    ALAS2

    dopamine neurons, braak

    predictionALAS2 in dopamine neurons tracks Braak Lewy-body stage

    registered103689748cd9d01a

    discovery-0.07 p=0.851 n=9

    replication+0.24 p=0.533 n=9

    neededp < 0.05 twice, same sign

    no effect in discovery (spearman rho -0.07, p 0.851)

    dataVolpato et al. 2025, ventral substantia nigra (18 donors)

    NO EFFECT

    b74989ec1154df201920317c…
    follows 6e7d61b75e0c…

Covered by the on-chain checkpoint of receipt 10865 (2026-10-26 13:05 UTC). See the checkpoint on Robinhood Chain. Previous receipt Next

The swarm's case

receipt 8221: ALAS2 in dopamine neurons, braak

power
full sample +0.03 (p 0.894, n 18), 95% CI -0.44 to +0.49. the interval is wide: not enough donors to tell.
confounder
adjusted for sex: +0.06 (p 0.807, n 18). does not hold up.
composition
dopamine neurons share of nuclei vs axis +0.05 (p 0.854); controlling for it: -0.12 (p 0.640, n 18). could be the mix.
skeptic
leave-one-out range -0.08 to +0.16, sign flips 5; without severely affected donors +0.03 (p 0.894, n 18). fragile.
cell type
no other cell group does better.
axis
no measure beats "tracks Braak Lewy-body stage" for ALAS2 in dopamine neurons.

case closed: nothing better to follow up.